Q1 Earnings Forecast for Quantum-Si Issued By HC Wainwright

Quantum-Si Incorporated (NASDAQ:QSI) – Equities research analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for Quantum-Si in a research note issued to investors on Monday, May 11th. HC Wainwright analyst S. Ramakanth anticipates that the company will earn ($0.13) per share for the quarter. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.50) per share. HC Wainwright also issued estimates for Quantum-Si’s Q2 2027 earnings at ($0.12) EPS, Q3 2027 earnings at ($0.12) EPS and Q4 2027 earnings at ($0.11) EPS.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.02. Quantum-Si had a negative return on equity of 46.05% and a negative net margin of 5,605.88%.The company had revenue of $0.26 million during the quarter, compared to the consensus estimate of $0.30 million.

Several other research analysts also recently issued reports on QSI. Canaccord Genuity Group lowered their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, March 4th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quantum-Si in a research note on Friday, March 27th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Quantum-Si has a consensus rating of “Hold” and a consensus price target of $3.25.

Quantum-Si Price Performance

Quantum-Si stock opened at $0.92 on Tuesday. The business has a 50 day moving average of $0.89 and a 200-day moving average of $1.18. Quantum-Si has a 1 year low of $0.69 and a 1 year high of $3.10. The company has a market capitalization of $199.54 million, a P/E ratio of -1.81 and a beta of 3.15.

Institutional Trading of Quantum-Si

Large investors have recently modified their holdings of the stock. Virtu Financial LLC acquired a new stake in shares of Quantum-Si during the 4th quarter worth approximately $262,000. IQ EQ FUND MANAGEMENT IRELAND Ltd grew its position in shares of Quantum-Si by 34.2% during the 4th quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 253,895 shares of the company’s stock worth $279,000 after buying an additional 64,721 shares during the period. Barclays PLC grew its position in shares of Quantum-Si by 21.8% during the 4th quarter. Barclays PLC now owns 269,415 shares of the company’s stock worth $296,000 after buying an additional 48,205 shares during the period. Quadrature Capital Ltd acquired a new stake in shares of Quantum-Si during the 4th quarter worth approximately $305,000. Finally, Rhumbline Advisers grew its position in shares of Quantum-Si by 7.8% during the 3rd quarter. Rhumbline Advisers now owns 219,965 shares of the company’s stock worth $310,000 after buying an additional 15,998 shares during the period. Institutional investors and hedge funds own 39.90% of the company’s stock.

Insider Activity

In other news, Director Paula Dowdy bought 109,890 shares of the firm’s stock in a transaction on Thursday, March 5th. The stock was acquired at an average price of $0.95 per share, with a total value of $104,395.50. Following the transaction, the director owned 269,107 shares of the company’s stock, valued at $255,651.65. This trade represents a 69.02% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Charles R. Kummeth bought 500,000 shares of the firm’s stock in a transaction on Thursday, March 5th. The shares were purchased at an average cost of $0.92 per share, with a total value of $460,000.00. Following the transaction, the director directly owned 855,000 shares in the company, valued at approximately $786,600. This trade represents a 140.85% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders sold 212,904 shares of company stock worth $205,021. 22.04% of the stock is owned by company insiders.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.